- Home
- Orthopedics
- Contents
BioMarin Achondroplasia Clinic invites you to a clinical webinar This first episode is organized by the esteemed Arab Society for Pediatric Endocrinology and Diabetes (ASPED) Focus on Achondroplasia: from disease burden to current management This educational session will feature a distinguished panel of experts, including Dr. Abdelhadi Habeb, Dr. I

Introduction Osteoporosis is a major health issue among older women, increasing the risk of fractures and reduced mobility (1). Consistent exercise combined with calcium and vitamin D supplementation is critical for maintaining bone health and preventing bone deterioration (1). This randomized controlled trial evaluated the effects of resistance tr

Introduction Polytrauma ranks as the third most common cause of mortality and is a major cause of long-term disability worldwide (1). Injury severity score of more than 15 or an Abbreviated Injury Scale ≥ 3 in at least two body parts, with one or more physiologic parameters (hypotension, unconsciousness, acidosis, coagulopathy, and age ≥70 years) c

Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves Two Denosumab Biosimilars in United States The FDA has approved two denosumab biosimilars for use in the U.S. One biosimilar is indicated for osteoporosis in men and women at high fracture risk. The other targets bone metasta





